FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Examines Office-Based Transperineal Prostate Biopsies Methodology.

2.

Atezolizumab Consolidation Impresses in High-Risk DLBCL

3.

AI could help improve early detection of interval breast cancers

4.

Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer

5.

Study identifies new target for obesity-related breast cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot